What's driving the Genomics in Cancer Care Market trends? Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnos
The global genomics in cancer care market size is anticipated to reach USD 14.6 billion by 2025 growing at a CAGR of 17.7% from 2019 to 2025 according to a new report. In 2018, by product type, instrument segment captures the largest market shares in terms of revenue and hold major share in the market. Regionally, North America accounted for the major share in the global market.
Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/1868600?utm_source=openpr.com&utm_medium=Abhijeet
The leading companies operating in this industry include Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnostics, Abbott Laboratories, PerkinElmer, and Luminex.
The report Genomics in Cancer Care Market Share, Size, Trends, & Industry Analysis Report, By Product type (Consumables, Instruments, Services); By Technology, By Application; By End Use; and By Region: Segment Forecast, 2019 - 2025 provides insights on the current market scenario and the future prospects.
The market is primarily driven by increasing prevalence of cancer patients globally, and rising demand for diagnostic coupled with the availability of cost effective and technologically advanced technology. Additionally, awareness and growing preference for personalized medicines is also influencing the market growth. Moreover, continuous investment on research and developments by the biotechnology & pharmaceutical companies would also fuel the market growth.
Product segment is further sub-segmented into consumables and reagents, instruments, and services. Instruments market holds the major share in the market owning to the rapid technological advancements, and continuous efforts by the manufacturers for providing digitalization in the instruments for its easy use. While consumables and reagents hold second largest position for market followed by the service sub segment.
Based on technology, the market is segmented as genome sequencing, PCR, microarray nucleic acid extraction and purification. Genome sequencing holds the major market share in 2017, and would continue to experience growth during the forecast period. The growth in this segment is majorly driven by the effective and precise diagnosis results, and rising awareness for its use in cancer diagnosis. Moreover, advantages like growing demand for cost-effective technologies, and flexibility in this technique would also influence the growth of genome sequencing market.
On the basis of application, the market is further segmented as diagnostics, personalized medicines, drug discovery, and Research. This application is majorly used for diagnosis of cancer. Diagnostics holds the largest market share which is majorly attributed to the growing number of cancer patients worldwide.
Research institute is the largest segment as an end user for the market, and would hold dominating position during the forecast period. The growth of genomics market in cancer care is primarily driven by the need for accurate screening techniques that gives to the point diagnosis of cancer.
Geographically, North America holds a dominating position in the global genomics in cancer care market followed by Europe and Asia Pacific. The market growth in North America is driven by the presence of refined research & development infrastructure for the researchers, large pool of patients suffering from cancer, and high healthcare expenditure by the individuals. Whereas, Asia Pacific is expected to reach remarkable growth owning to the increased penetration rate of these technologies and improving research and development expenditure by the biopharma industries.
Key Findings from the study suggest technology available in the market are continuously concentrating on the technological advancements that will reduce the efforts and provide with accurate diagnosis of cancer. The leading companies while developing new technologies considers the factors such as increasing awareness for the use of this technology, and reaching the untapped market. North America is presumed to dominate the global market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.
The Report has segmented the genomics in cancer care market on the basis of product type, technology, application, end user and region:
Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/1868600?utm_source=openpr.com&utm_medium=Abhijeet
Genomics in Cancer Care Product Type Outlook
Genomics in Cancer Care Technology Type Outlook
Microarray Nucleic Acid Extraction and Purification
Genomics in Cancer Care Application Outlook
Genomics in Cancer Care Product End Use Outlook
Table of Contents
1. Overview and Scope
2. Executive Summary
3. Genomics in Cancer Care Market Insights
4. Genomics in Cancer Care Market Size and Forecast, by Product Types
5. Genomics in Cancer Care Market Size and Forecast, by Technology Type
6. Genomics in Cancer Care Market Size and Forecast, by Application
7. Genomics in Cancer Care Market Size and Forecast, by End Use
8. Genomics in Cancer Care Market Size and Forecast, by Region
9. Company Profiles
9.1. Aligent Technologies
9.2. Roche Diagnostics
9.3. Beckman Coulter
9.4. Illumina, Inc.
9.6. Cancer Genetic Inc.
9.7. Bio-rad Labs
9.8. Pacific Bio-Sciences
9.9. Sigma Aldrich Corporation
9.10. GE Healthcare
9.11. Quest Diagnostics
9.12. Abbott Laboratories
buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/1868600?utm_source=openpr.com&utm_medium=Abhijeet
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the Genomics in Cancer Care Market trends? Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnos here
News-ID: 1748285 • Views: 272
More Releases from marketstudyreport.com
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides
What's driving the Quantum Cryptography Market growth? IBM, Infineon Technologie …
The quantum cryptography market is at a nascent stage with massive potential to break through the cybersecurity industry. The quantum cryptography market players are constantly engaging themselves in advancing their features intending to offer highly secured solutions to their clients. The global quantum cryptography market accounted for US$ 105.3 Mn in 2018 and is expected to grow at a CAGR of 39.2% over the forecast period 2019-2027, to account for
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and